Kolexia
Cojocarasu Oana Oncologie médicale
Cojocarasu Oana
Oncologie médicale
Centre Hospitalier du Mans
Le Mans, France
68 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Métastase tumorale Tumeurs du sein Tumeurs de l'ovaire Tumeurs du côlon Déficit en dihydropyrimidine déshydrogénase Adénocarcinome Néphrocarcinome Prédisposition génétique à une maladie

Collaborateurs

Voir plus
Guerin-Meyer Veronique
Guerin-Meyer Veronique
Ico - Site Paul Papin, Angers, France
Seuwin Benoit
Seuwin Benoit
Centre Hospitalier du Mans, Le Mans, France
Faroux Roger
Faroux Roger
Centre Hospitalier Départemental Vendée, La Roche-sur-Yon, France
Bourgeois Hugues
Bourgeois Hugues
Gcs Medecine Nucleaire Sarthe_et Siege, Le Mans, France

Industries

Voir plus
Pfizer
3 collaboration(s)
Dernière en 2022
Sanofi
2 collaboration(s)
Dernière en 2021
Advanced Accelerator Applications
2 collaboration(s)
Dernière en 2022
Merck-Serono
1 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
MYCA: Phase Ib / II Trial Evaluating the Association Myocet ® - Carboplatine in Patients Having a Cancer of the Ovary in Relapse, Sensitive to the Platinum
Essai Clinique (ARCAGY/ GINECO GROUP)   05 septembre 2023
The place of the relative at the time of the announcement of cancer progression: BABEL - a mixed-methods study.
Palliative & supportive care   26 juin 2023
Perioperative Cetuximab with Cisplatin and 5-Fluorouracil in Esogastric Adenocarcinoma: A Phase II Study.
Cancers   06 avril 2023
Geriatric Assessment Implementation before Chemotherapy in MEtastatic Prostate Cancer, Results from the Real-Life Study GAMERS.
Journal of clinical medicine   18 février 2023
IPPACTTO: Pharmaceutical Intervention in the Coordinated Care Pathway for Cancer Patients Treated With Oral Therapy
Essai Clinique (Institut Cancerologie de l'Ouest)   21 avril 2022
Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab: Phase II, Multicentric Randomized Trial, Evaluating the Efficacy of Fluoropyrimidine-based Standard Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab
Essai Clinique (Unicancer)   07 janvier 2022
Building a biopsychosocial model of cancer-related fatigue: the BIOCARE FActory cohort study protocol.
BMC cancer   23 octobre 2021
Efficacy and safety of panitumumab in a cohort of patients with metastatic colorectal cancer in France: PANI OUEST, a post-EMA-approval descriptive study with a geriatric oncology focus.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology   14 octobre 2021
BIOpsychosocial Approach of the CAncer-RElated FAtigue (BIOCARE FActory): BIOpsychosocial Approach of the CAncer-RElated FAtigue
Essai Clinique (Le Mans Universite)   17 septembre 2020
Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal Cancer: Multicenter Phase III Randomized Study of FOLFIRI Plus Bevacizumab Following or Not by a Maintenance Therapy With Bevacizumab in Patients With Non-Pretreated Metastatic Colorectal Cancer
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   27 mars 2020